Lansoprazole: all 91 studies that test it

Page 1 of 1. Open to participants first (4), then studies with results posted, then the rest; newest registration first within each.

• Neuroregulators for the Treatment of Diseases Associated With Esophageal-brain-gut Axis Communication Abnormalities.RecruitingNCT06778824Not applicable
• A "Screen and Treat" Helicobacter Pylori Eradication Trial in Adolescents in Three Regions of ChileRecruitingNCT05926804Not applicable
• The Efficacy and Safty of Proton Pump Inhibitor (Lansoprazole)Not yet recruitingNCT05820048Phase 4
• Treating People With Idiopathic Pulmonary Fibrosis With the Addition of LansoprazoleRecruitingNCT04965298Phase 3
• Effect of Obesity on Proton Pump InhibitorsCompletedNCT04248335Phase 4Results posted
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Duodenal Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050359Phase 3Results posted
• Comparison of TAK-438 (Vonoprazan) to Lansoprazole in the Treatment of Gastric Ulcer Participants With or Without Helicobacter Pylori InfectionCompletedNCT03050307Phase 3Results posted
• Efficacy and Safety of Dexlansoprazole in Healing and Maintaining Healing of Erosive EsophagitisTerminatedNCT02873702Phase 3Results posted
• Combination Therapy With Sitagliptin and Lansoprazole to Restore Pancreatic Beta Cell Function in Recent-Onset Type 1 DiabetesCompletedNCT01155284Phase 2Results posted
• Safety and Efficacy of Lansoprazole in Patients With Reflux DiseaseCompletedNCT01135368Phase 4Results posted
• Lansoprazole 30 mg DR Capsule Fasting Replicate Sprinkle StudyCompletedNCT01046253Phase 1Results posted
• Lansoprazole 30 mg DR Capsule Replicate Food StudyCompletedNCT01046084Phase 1Results posted
• Lansoprazole 30 mg DR Capsule Fasting StudyCompletedNCT01045967Phase 1Results posted
• Proof of Concept Study Efficacy of an Antacid/Lansoprazole Combination for Relief of HeartburnCompletedNCT01037452Phase 2Results posted
• A Study of the Effects of Multiple Doses of Dexlansoprazole, Lansoprazole, Omeprazole or Esomeprazole on the Pharmacokinetics and Pharmacodynamics of Clopidogrel in Healthy Participants.CompletedNCT00942175Phase 1Results posted
• Novel Therapy to Preserve Beta Cell Function in New Onset Type 1 DiabetesTerminatedNCT00837759Phase 2Results posted
• 13-C Urea Breath Test Using BreathID System and PPIs (Proton Pump Inhibitors)CompletedNCT00825630Phase 4Results posted
• Efficacy and Safety of Lansoprazole on Gastric and Duodenal Ulcers in Patients Taking Nonsteroidal Anti-Inflammatory DrugsCompletedNCT00787254Phase 3Results posted
• A Safety and Efficacy Study of Lansoprazole in Preventing Aspirin-Induced Gastric and Duodenal UlcersTerminatedNCT00762359Phase 3Results posted
• Use of Topical Budesonide in the Treatment of Eosinophilic EsophagitisCompletedNCT00638456Phase 2Results posted
• A Clinical Trial of Proton Pump Inhibitors to Treat Children With Chronic Otitis Media With EffusionCompletedNCT00546117Not applicableResults posted
• The Effects of Reducing Stomach Acid on Post-tonsillectomy PainTerminatedNCT00472186Phase 4Results posted
• Do Laryngeal Tissue Changes in Patients Suspected of Having Laryngopharyngeal Reflux Predict Response to Treatment?CompletedNCT00444145Phase 4Results posted
• Lansoprazole to Treat Children With AsthmaCompletedNCT00442013Phase 4Results posted
• Safety and Efficacy of Lansoprazole 30mg Twice Daily in Treatment of Laryngitis Associated With Gastroesophageal RefluxTerminatedNCT00369265Phase 4Results posted
• Elucidation of Acid-Induced Pulmonary InflammationTerminatedNCT00361972Phase 2/3Results posted
• Efficacy of Lansoprazole in Chronic Post Nasal DripCompletedNCT00335283Phase 3Results posted
• Investigation of the Association Between Nasal Polyposis and Extraesophageal Reflux DiseaseCompletedNCT00215787Not applicableResults posted
• Treatment of Zollinger-Ellison Syndrome With PrevacidCompletedNCT00204373Phase 4Results posted
• A Study to Compare PK/PD Characteristics and Safety Profiles Between AD-212-A and AD-2121CompletedNCT06025773Phase 1
• Medicine-induced Cardiac Hemodialysis on COVID-19CompletedNCT05711810Phase 4
• A Study to Evaluate the Safety, Tolerability and Pharmacokinetics/Pharmacodynamics of Oral Doses of H008CompletedNCT05050188Phase 1
• The Possible Efficacy and Safety of Lansoprazole Co-administration With Neoadjuvant Chemotherapy in Women With Breast CancerCompletedNCT04874935Phase 3
• Response to Oral Lansoprazole of Inorganic Pyrophosphate Levels in Patients With Grönblad-Stranberg Disease (Pseudoxanthoma Elasticum)Status unknownNCT04660461Phase 4
• Study to Evaluate the Safety and Efficacy of X842 in Patients With Reflux EsophagitisCompletedNCT04531475Phase 2
• PPI Therapy Impact on GERD After Sleeve GastrectomyStatus unknownNCT04400136Early Phase 1
• A Comparison of High-dose Dual Therapy and Half-dose Clarithromycin-containing Bismuth Quadruple Therapy for H.P Eradication in Elderly PatientsStatus unknownNCT04101708Phase 4
• AZD4635 Relative Bioavailability StudyCompletedNCT03710434Phase 1
• Intraluminal Metronidazole Powder Monotherapy for Helicobacter Pylori InfectionCompletedNCT03524833Phase 4
• PK-PD Comparative Study of Lansoprazole Capsules and Lansoprazole Enteric-coated Capsules in Healthy Chinese VolunteersCompletedNCT03488186Phase 1
• Pharmacokinetic Study of Lansoprazole Capsules in Healthy Chinese VolunteerCompletedNCT03488173Phase 1
• Cardiac Safety of Lansoprazole and Domperidon CombinationWithdrawnNCT03355170Phase 4
• Intraluminal Therapy for Helicobacter Pylori InfectionCompletedNCT03124420Phase 4
• Study to Assess the Relative Bioavailability of Fixed-Dose Combination (FDC) Tablet (Simeprevir, Odalasvir and AL-335) Compared With Single Agents Administered Together, and to Assess the Effect of Multiple-Dose Lansoprazole or Omeprazole on Single-Dose Pharmacokinetics of SMV, ODV, and AL-335 (FDC)TerminatedNCT03059303Phase 1
• The Efficacy of Lansoprazole and Domperidone Combination on Intragastric and Intraesophageal AcidityCompletedNCT02958046Phase 4
• First-line Antibiotic Therapy for Early-stage HP(+) Gastric Pure DLBCLStatus unknownNCT02388581Phase 2
• Open-label PK Study to Evaluate Lansoprazole and Neratinib in Healthy SubjectsCompletedNCT02334501Phase 1
• The Relationship Between Gastroesophageal Reflux and Pediatric Rhinitis: Significance of Pale/Blue Colored TurbinateStatus unknownNCT02278081Phase 4
• Effect of Proton Pump Inhibitors on Endothelial FunctionCompletedNCT02022280Phase 1
• Lansoprazole in Preterm Infants With Gastroesophageal Reflux (GER)CompletedNCT01946971Phase 1/2
• Effects of Lansoprazole on Sitagliptin Glucose-lowering Ability in Healthy Males: a Randomised Crossover StudyCompletedNCT01820104Phase 1
• Lansoprazole in Preterm Infants With RefluxCompletedNCT01778101Phase 2
• The Insulin Independence Trial (IIT) Evaluating the Safety and Efficacy of Oral Cyclosporine and Oral Lansoprazole for Insulin Independence Among Patients With Existing Type 1 DiabetesWithdrawnNCT01762657Phase 3
• Clarithromycin-based Triple Therapy for 14 Days Versus Sequential Therapy 10 Days in the First Line TherapyStatus unknownNCT01607918Phase 4
• Comparison of the Efficacy of Levofloxacin-based Sequential Therapy and Triple Therapy as Second Line TherapyStatus unknownNCT01537055Phase 4
• Helicobacter Eradication Aspirin TrialCompletedNCT01506986Phase 4
• Efficacy of TAK-438, Amoxicillin and Clarithromycin in the First Line Eradication of H. PyloriCompletedNCT01505127Phase 3
• CLL Empirical Antibiotic RegimenCompletedNCT01279252Phase 2
• Bioequivalence Study of Lansoprazole DR Capsules 30 mg in Fasting ConditionsCompletedNCT01270308Phase 1
• Evaluation of Methods for the Determination of Chromogranin A in Routine Blood SamplesCompletedNCT01216267Not applicable
• Oral Versus IV Proton Pump Inhibitor in High-risk Bleeding Peptic Ulcers After Endoscopic HemostasisStatus unknownNCT01182597Phase 3
• PPI vs H2RA in Patients With Helicobacter Pylori-Negative Idiopathic Bleeding UlcersCompletedNCT01180179Phase 4
• Study Evaluating Effect of Esomeprazole, Omeprazole or Lansoprazole on the Pharmacodynamics (PD) and Pharmacokinetics (PK) of ClopidogrelCompletedNCT01147588Phase 1
• Efficacy and Safety Evaluation of Levofloxacin Triple Therapy for Helicobacter Pylori EradicationCompletedNCT01131026Phase 3
• Oral vs Intravenous and Proton Pump Inhibitor (PPI）for Peptic Ulcer Bleeding (PUB)WithdrawnNCT01123031Phase 4
• Study of Anti-reflux Medication as a Potential Treatment for Glue Ear in ChildrenCompletedNCT01082029Phase 4
• Lansoprazole for Subgroups of Functional DyspepsiaTerminatedNCT01040455Phase 4
• The Effects of Helicobacter Pylori Eradication on Proteinuria in Patients With Membranous NephropathyCompletedNCT00983034Not applicable
• Study Evaluating The Potential Effect Of Lansoprazole On The Pharmacokinetics Of Bosutinib In Healthy SubjectsCompletedNCT00952913Phase 1
• Twice Daily Prevacid for the Treatment of Laryngopharyngeal RefluxCompletedNCT00864396Phase 1
• Peptic Ulcer Disease in Ischemic Heart Patients Taking Aspirin and Clopidogrel With or Without Proton Pump InhibitorStatus unknownNCT00854776Not applicable
• Efficacy/Safety of Lansoprazole in Patients With Frequent Nighttime HeartburnCompletedNCT00701259Phase 3
• Lansoprazole Versus Mosapride for Functional DyspepsiaCompletedNCT00663897Phase 4
• A Randomized, Open-Label, Comparative 3-Way Treatment Crossover Study of 24-Hour Intragastric pH Profile of Once Daily Oral Administration of Esomeprazole 40mg, Lansoprazole 30mg, and Pantoprazole 40mg at Steady State in NSAID-Using PatientsCompletedNCT00625274Phase 4
• Trial of Oral Versus Intravenous Proton Pump Inhibitor on Intragastric pH in Patients With Bleeding UlcersCompletedNCT00573924Not applicable
• Helicobacter Pylori Infection in Children With Chronic Idiopathic Thrombocytopenic PurpuraCompletedNCT00467571Phase 4
• Pharmacokinetic Study of Lansoprazole in Cystic FibrosisCompletedNCT00458614Phase 1
• Evaluation of 24-Hour Intragastric pH Using Esomeprazole, Lansoprazole, and Pantoprazole in Hispanic Patients With GERDCompletedNCT00410592Phase 4
• Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNCT00390390Phase 3
• Efficacy/Safety of Lansoprazole in Patients With Frequent HeartburnCompletedNCT00389948Phase 3
• An Open Label pH Comparison of Esomeprazole and Lansoprazole in Barrett's Esophagus PatientsCompletedNCT00352261Phase 4
• Randomized Trial for Pharmacogenomics-based Proton Pump Inhibitor Therapy in ChildrenWithdrawnNCT00299845Phase 4
• Prevacid vs Lifestyle Modifications for the Treatment of LPRStatus unknownNCT00274339Not applicable
• Effect of Prevacid on Prostaglandin Levels in Patient With Stress UlcerCompletedNCT00239551Phase 4
• A Randomized, Double-Blind, Placebo-Controlled Study of Gastroesophageal Reflux Disease Therapy.Status unknownNCT00237068Phase 4
• Lansoprazole Preventing Gastroduodenal Stress UlcerationsTerminatedNCT00220909Phase 4
• A Study to Evaluate the Effect of Lansoprazole on Infants With Gastroesophageal Reflux Disease.CompletedNCT00220818Phase 1
• Intravenous vs Oral Lansoprazole on Gastric Acid Secretion in Subjects With Erosive EsophagitisCompletedNCT00175045Phase 2
• A Comparison of Safety and Treatment in Subjects With Osteoarthritis Taking Low Dose AspirinCompletedNCT00175032Phase 3
• A Study to Evaluate the Effect of Lansoprazole on Hospitalized Neonates With Gastroesophageal Reflux DiseaseCompletedNCT00174928Phase 1
• Tailored Treatment of H. Pylori Infection Based Polymorphisms of CYP2C19 and 23S rRNA of H. PyloriStatus unknownNCT00149084Phase 3

← Lansoprazole overview